跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MINT-LEVOCARB
Authorized
STANDARD
MINT-LEVOCARB
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
71a4a93853735607
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
71a4a93853735607
Drug Approval Canada Name
MINT-LEVOCARB
Product Name
MINT-LEVOCARB
Status
Dormant
Status Date
2017-05-02
Original Market Date
2016-11-03
Din
02457954
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:36.16
Atc Original
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Atc Name
n 04 ba 02
Aig Number
0210315002
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
CARBIDOPA
10 MG
LEVODOPA
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
71a4a93853735607
Type
Standard
Back to Health Canada Approvals
MINT-LEVOCARB - Health Canada Drug Approval Details